EGLN2 and chronic obstructive pulmonary disease: Moreover, increased EGLN2 expression is associated with impaired epithelial junctional barrier function leading to increased epithelial permeability [32], which is a characteristic of the airway epithelium of healthy and COPD smokers [18].